Germany's CureVac NV said on Tuesday it has started a midstage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers in the fourth quarter.from Top Business News- News18.com https://ift.tt/36hX4sl
Comments
Post a Comment